Inhaled Anesthetics is fastest growing segment fueling the growth of General Anesthesia Drugs Market

 

General anesthesia can induce amnesia, analgesia, immobility and unconsciousness. It is often used for surgical procedures, medical imaging scans, and some minor procedures. General anesthesia products include inhaled anesthetics, intravenous anesthetics, and anesthesia machines.

The global General Anesthesia Drugs Market is estimated to be valued at US$ 4.95 Bn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
 
Market key trends:
Inhaled anesthetics are widely used due to their quick onset and offset of action, easy control and advantages over intravenous anesthetics in certain surgeries. Some of the key inhaled anesthetics adopted are sevoflurane, desflurane and isoflurane. Additionally, technological advancements in anesthesia delivery systems have improved patient safety and enabled higher accuracy in drug delivery. There is an increasing adoption of customized anesthesia protocol to optimize perioperative outcomes. Development of synergistic drug combinations and localized drug delivery systems are new trends gaining attention in the market.
Segment Analysis
The general anesthesia drugs market can be segmented by product and application. Based on product, the market is segmented into intravenous anesthesia drugs and inhalational anesthesia drugs. The inhalational anesthesia drugs segment currently dominates the market due to its widespread use in several surgical procedures. Inhalational anesthesia drugs such as sevoflurane, desflurane, and nitrous oxide offer advantages such as rapid onset and recovery time, lower cost compared to intravenous drugs, ease of administration through inhalation, and better controllability of anesthesia depth through inhalation.

Key Takeaways
The global general anesthesia drugs market size is expected to reach US$ 6.95 billion by 2030, expanding at a CAGR of 4.1% over the forecast period. Growing volume of surgical procedures across the globe is a major factor contributing to market growth. North America currently holds the largest market share owing to high healthcare spending and availability of advanced healthcare facilities. However, Asia Pacific is expected to witness the fastest growth due to improving healthcare infrastructure and increasing medical tourism in countries such as India, China, and Thailand. Key players operating in the general anesthesia drugs market are Baxter Healthcare, Dr. Reddy's Laboratories, Novartis International AG, Hospira, Maruishi, Hengrui, Lunan, Fresenius Kabi, Pfizer Inc., Hikma Pharmaceuticals, Sagent Pharmaceuticals, Teva Pharmaceuticals, Par Pharmaceutical, Viatris Inc., AbbVie, Piramal Critical Care, Aspen Global Incorporated, B. Braun SE, Abbott and Cosmo pharmaceuticals. These players mainly focus on new product launches and expanding their geographical presence to strengthen market position.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more